ABBVIE BIOTECHNOLOGY LTD.
Patent Owner
Stats
- 105 US PATENTS IN FORCE
- 15 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 105 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 12,482 Total Citation Count
- Feb 09, 1996 Earliest Filing
- 45 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0101,465 Use of TNFalpha Antibody for Treatment of Hidradenitis Suppurativa (HS)May 06, 16Apr 13, 17[A61K, C07K, A61M]
2017/0022,271 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERSOct 07, 16Jan 26, 17[A61K, C07K]
2016/0297,879 Uses and Compositions for Treatment of Psoriatic ArthritisNov 18, 15Oct 13, 16[A61K, C07K]
2016/0280,776 Uses and Compositions for Treatment of Juvenile Rheumatoid ArthritisNov 09, 15Sep 29, 16[G01N, C07K]
2016/0220,765 REMOVAL OF NEEDLE SHIELD FROM SYRINGES AND AUTOMATIC INJECTION DEVICESApr 08, 16Aug 04, 16[A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9878102 Automatic injection devices having overmolded gripping surfacesFeb 18, 16Jan 30, 18[B23P, B05D, A61B, A61M]
9821117 Wearable automatic injection device for controlled delivery of therapeutic agentsOct 01, 15Nov 21, 17[A61M]
9750808 Formulation of human antibodies for treating TNF-alpha associated disordersJan 27, 17Sep 05, 17[A61K, C07K]
9738714 Formulation of human antibodies for treating TNF-alpha associated disordersJan 27, 17Aug 22, 17[A61K, C07K]
9732152 Formulation of human antibodies for treating TNF-alpha associated disordersJan 27, 17Aug 15, 17[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0157,249 USES AND COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITISAbandonedJul 21, 16Jun 08, 17[A61K, G01N]
2017/0044,249 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSAbandonedJun 19, 15Feb 16, 17[A61K, C07K]
2016/0251,424 Uses and Compositions for Treatment of Ankylosing SpondylitisAbandonedMar 07, 16Sep 01, 16[A61K, C07K]
2015/0064,194 Uses and Compositions for Treatment of Rheumatoid ArthritisAbandonedOct 28, 14Mar 05, 15[A61K, C12N]
2014/0377,275 HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONSAbandonedAug 29, 14Dec 25, 14[C07K]
2014/0296,493 METHOD OF TREATING DEPRESSION USING A TNFa ANTIBODYAbandonedFeb 05, 14Oct 02, 14[A61K, C07K]
2014/0248,275 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERSAbandonedMar 28, 14Sep 04, 14[A61K]
2014/0248,276 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERSAbandonedMar 28, 14Sep 04, 14[C07K]
2014/0212,430 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERSAbandonedMar 28, 14Jul 31, 14[C07K]
2014/0200,332 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNF-ALPHA ACTIVITY IS DETRIMENTALAbandonedFeb 19, 14Jul 17, 14[C07K]
2014/0186,368 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIESAbandonedFeb 07, 14Jul 03, 14[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.